ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹7,247 Cr | ₹6,866 Cr | ₹6,810 Cr | ₹3,472 Cr | ₹2,113 Cr |
What is the latest Total Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹7,247 Cr |
| Mar2025 | ₹6,866 Cr |
| Mar2024 | ₹6,810 Cr |
| Mar2023 | ₹3,472 Cr |
| Mar2022 | ₹2,113 Cr |
How is Total Liabilities of ERIS LIFESCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,247 Cr | 5.55 | |
| Mar2025 | ₹6,866 Cr | 0.81 | |
| Mar2024 | ₹6,810 Cr | 96.16 | |
| Mar2023 | ₹3,472 Cr | 64.33 | |
| Mar2022 | ₹2,113 Cr | - | |
Compare Total Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,508.0 Cr | 2.4% | -4.2% | -24.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,316.0 Cr | -1.9% | -3.7% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,737.0 Cr | 2.6% | 11.1% | 56% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,594.0 Cr | 0.2% | 1.3% | 38% | Stock Analytics | |
| CIPLA | ₹110,515.0 Cr | -1.5% | -6.4% | -12.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.6 Cr | -1% | -5.1% | -8.1% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 2.4% |
-4.2% |
-24.6% |
| SENSEX | -2.4% |
-4.8% |
-7.2% |
You may also like the below Video Courses